The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-22
DOI
10.1038/s41598-020-65353-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Poly(ADP-ribose) polymerase inhibitors as maintenance treatment in patients with newly diagnosed advanced ovarian cancer: a meta-analysis
- (2020) Ezzeldin M Ibrahim et al. Future Oncology
- Combinatorial therapy of immune checkpoint and cancer pathways provides a novel perspective on ovarian cancer treatment (Review)
- (2019) Guyu Zhang et al. Oncology Letters
- Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6
- (2019) Nicole E. James et al. Frontiers in Pharmacology
- PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
- (2018) Robert D. Morgan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The role of STAT3 in leading the crosstalk between human cancers and the immune system
- (2018) Yu Wang et al. CANCER LETTERS
- HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells
- (2018) Nicole E. James et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Personalising Treatment for High-Grade Serous Ovarian Carcinoma
- (2018) E. Cojocaru et al. CLINICAL ONCOLOGY
- Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix
- (2018) Jennifer R. Ribeiro et al. Frontiers in Oncology
- Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab
- (2018) Ryota Tamura et al. CANCER SCIENCE
- Hypoxia-Induced Upregulation of HE4 Is Responsible for Resistance to Radiation Therapy of Gastric Cancer
- (2018) Chunwei Peng et al. Molecular Therapy-Oncolytics
- Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
- (2017) Marcela Moisés Maluf Sanguinete et al. IMMUNOLOGICAL INVESTIGATIONS
- The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment
- (2017) Nakho Chang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer
- (2017) Jian-Feng Liu et al. MOLECULAR CARCINOGENESIS
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
- (2017) G Jin et al. Oncogenesis
- Immune checkpoint inhibition in ovarian cancer
- (2016) Junzo Hamanishi et al. INTERNATIONAL IMMUNOLOGY
- Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer
- (2016) Seungho Lee et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells
- (2016) Liancheng Zhu et al. ONCOLOGY REPORTS
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
- (2016) J. R. Ribeiro et al. Journal of Ovarian Research
- Bevacizumab in ovarian cancer: A critical review of phase III studies
- (2016) Luigi Rossi et al. Oncotarget
- Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation
- (2016) Hualin Fu et al. Scientific Reports
- Regulation of PD-L1: a novel role of pro-survival signalling in cancer
- (2015) J. Chen et al. ANNALS OF ONCOLOGY
- Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis
- (2015) S K Srivastava et al. BRITISH JOURNAL OF CANCER
- Interleukin-8: A potent promoter of angiogenesis in gastric cancer
- (2015) JUN SHI et al. Oncology Letters
- Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer
- (2015) Liancheng Zhu et al. Oncotarget
- Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells
- (2014) Huiyu Zhuang et al. BIOCHIMIE
- Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner
- (2014) Heyang Xu et al. BMC CANCER
- The Angiogenic Activity of Ascites in the Course of Ovarian Cancer as a Marker of Disease Progression
- (2014) Krzysztof Gawrychowski et al. DISEASE MARKERS
- Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells
- (2014) Huiyu Zhuang et al. Molecular Cancer
- Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells
- (2014) HUAN WANG et al. ONCOLOGY REPORTS
- Expression and biochemical characterization of recombinant human epididymis protein 4
- (2014) Ling Hua et al. PROTEIN EXPRESSION AND PURIFICATION
- HE4 (WFDC2) gene overexpression promotes ovarian tumor growth
- (2014) Richard G. Moore et al. Scientific Reports
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesisin vitro
- (2013) Xipeng Wang et al. CANCER SCIENCE
- Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma
- (2013) Sung Hoon Choi et al. LIVER INTERNATIONAL
- Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro
- (2013) Ya-Fei Zhu et al. Asian Pacific Journal of Tropical Medicine
- Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility
- (2012) Renquan Lu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting Stat3 Induces Senescence in Tumor Cells and Elicits Prophylactic and Therapeutic Immune Responses against Breast Cancer Growth Mediated by NK Cells and CD4+ T Cells
- (2012) M. Tkach et al. JOURNAL OF IMMUNOLOGY
- Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation
- (2011) Erin M. Bekes et al. AMERICAN JOURNAL OF PATHOLOGY
- Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells
- (2009) Masahiro Oka et al. EXPERIMENTAL DERMATOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1 RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells
- (2008) G. Niu et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now